Tabula Rasa Healthcare

Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services. Its brands include CareKinesis, Capstone Risk Adjustment Services, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides Medication Therapy Management, or MTM, software and services for Medicare, Medicaid, and commercial health plans, and also provides a cloud-based patient engagement software and services. It offers cloud-based software and clinical pharmacist services through its brands, including MedWise, SinfoníaRx, RxCompanion, PrescribeWellness, and DoseMeRx. The company was founded by Calvin H. Knowlton, Orsula V. Knowlton, and Michael Greenhalgh in April 2009 and is headquartered in Moorestown, NJ.

Earnings data Q4 2019

Earnings data Q1 2020

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q2 2024

Tabula Rasa HealthCare reports robust Q4 growth and strategic investments

Tabula Rasa HealthCare's Q4 2022 performance reflects strong revenue growth and strategic initiatives to enhance profitability.
While facing challenges in technology-enabled solutions revenue and execution risks, the company is well-positioned for growth.
Opportunities in automation investments and MedWise platform expansion offer avenues for sustained revenue growth and market impact.

Tabula Rasa HealthCare (TRHC) excels in Q1 2023 earnings, eyes expansion

Tabula Rasa HealthCare (TRHC) delivered strong financial performance in Q1 2023, driven by revenue growth, profitability focus, and strategic initiatives.
The company faces challenges from drug price inflation and contract turnover impact but is well-positioned for future expansion and market penetration.
TRHC's emphasis on customer-centric strategies, PACE program growth, and efficient resource management sets the stage for continued success and revenue growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tabula Rasa provides state-of-the-art medication management through a combination of technology, science and services that reduces costs, improves the quality of care and decreases the risks associated with ineffective medication plans.

Aphria

Huron Consulting Group

InterDigital

Ionis Pharma

Invest in top-ranked stocks that are likely to beat their earnings estimates in the upcoming releases.

Grab 5 Top Stocks With Strong Earnings Beat Prospects

MOORESTOWN, N.J., April  16, 2020  (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced an expanded laboratory services agreement with  CQuentia , a comprehensive analytics platform and molecular laboratory for personalized medicine. The agreement provides TRHC with access to COVID-19 (SARS-CoV-2 RNA) testing kits for distribution to Programs of All-Inclusive Care for the Elderly (PACE) through TRHC’s  CareKinesis Pharmacy .

Tabula Rasa HealthCare® and CQuentia® Expand Partnership with COVID-19 Test Kit Distribution Agreement

Over 3,000 independent pharmacies that utilize TRHC’s PrescribeWellness solution have volunteered to be testing sites Over 3,000 independent pharmacies that utilize TRHC’s PrescribeWellness solution have volunteered to be testing sites

TRHC Provides COVID-19 Testing Opportunities to Community Pharmacies Across the United States

EPN will use PrescribeWellness Solutions to Improve Patient Care Across the U.S. EPN will use PrescribeWellness Solutions to Improve Patient Care Across the U.S.

EPIC Pharmacy Network Renews Contract with TRHC’s PrescribeWellness®

DoseMeRx to integrate with VigiLanz clinical surveillance solutions for hospitals DoseMeRx to integrate with VigiLanz clinical surveillance solutions for hospitals

VigiLanz® Announces Precision Dosing Powered by Tabula Rasa HealthCare’s DoseMeRx™

Veteran Healthcare Technology Research Analyst Joins TRHC to Lead Investor Relations Veteran Healthcare Technology Research Analyst Joins TRHC to Lead Investor Relations

Tabula Rasa HealthCare® Names Frank Sparacino SVP Investor Relations and Corporate Development

Is  (TRHC) Outperforming Other Medical Stocks This Year?

Is Tabula Rasa Healthcare (TRHC) Stock Outpacing Its Medical Peers This Year?

Testing Kits are available for all PACE Organizations Testing Kits are available for all PACE Organizations

Tabula Rasa HealthCare® is Providing Programs of All-Inclusive Care for the Elderly (PACE) Access to COVID-19 Testing Kits

TRHC Board of Directors is 55% Women TRHC Board of Directors is 55% Women

2020 Women on Boards Honors Tabula Rasa HealthCare for Having at Least 20% Women on its Corporate Board

Tabula Rasa HealthCare and BioIntelliSense Partnership enables remote monitoring including symptoms of COVID-19 Tabula Rasa HealthCare and BioIntelliSense Partnership enables remote monitoring including symptoms of COVID-19

Tabula Rasa HealthCare Named Principal Distributor of the BioIntelliSense BioSticker™ for Programs of All-Inclusive Care for the Elderly (PACE)

Tabula Rasa HealthCare, Inc. (TRHC) CEO Calvin Knowlton on Q4 2019 Results - Earnings Call Transcript

Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Tabula Rasa Healthcare (TRHC) Q4 Earnings Expected to Decline

Tabula Rasa Healthcare saw its IBD SmartSelect Composite Rating rise to 96 Wednesday, up from 94 the day before.

Medical Software Firm Tabula Rasa Earns 95-Plus Composite Rating

PACE Place of Jacksonville, FL will help keep participants living in their homes PACE Place of Jacksonville, FL will help keep participants living in their homes

TRHC Signs Agreement to Provide CareVention HealthCare® Services to New PACE Organization

MOORESTOWN, N.J., Jan.  13, 2020  (GLOBE NEWSWIRE) --   Tabula Rasa HealthCare®  , Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced today a client retention rate of 99.1% in the PACE (Programs of All-inclusive Care for the Elderly) market to begin 2020.

Tabula Rasa HealthCare Retains 99.1% of PACE Clients to Start 2020

TRHC will start 2020 with Five New PACE Contracts

Tabula Rasa HealthCare Reports Steady Growth in its CareVention HealthCare™ Division

Hudson Headwaters will be first Federally Qualified Health Center to utilize TRHC’s MedWise™ software solution Hudson Headwaters will be first Federally Qualified Health Center to utilize TRHC’s MedWise™ software solution

Tabula Rasa HealthCare Expands into a New Market with Hudson Headwaters Health Network Contract

The partnership with WelbeHealth demonstrates TRHC’s commitment to help grow PACE organizations in California and nationwide The partnership with WelbeHealth demonstrates TRHC’s commitment to help grow PACE organizations in California and nationwide

TRHC Announces the Execution of a Pharmacy Services Agreement with WelbeHealth

Tabula Rasa HealthCare, Inc. (TRHC) CEO Calvin Knowlton on Q3 2019 Results - Earnings Call Transcript

Allscripts Healthcare Solutions

MDRX vs. TRHC: Which Stock Is the Better Value Option?

MDRX or TRHC: Which Is the Better Value Stock Right Now?

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 22.22% and -1.46%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Tabula Rasa Healthcare (TRHC) Beats Q3 Earnings Estimates

Earnings Preview: Tabula Rasa Healthcare (TRHC) Q3 Earnings Expected to Decline

MOORESTOWN, N.J., Oct.  28, 2019  (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces today that its CareVention HealthCare Division is providing medication safety and pharmacy services, along with electronic health record and health plan management services, for the Gary and Mary West PACE program in San Marcos, California, which held its official opening October 10, 2019.

TRHC’s CareVention HealthCare to Provide Medication Safety and Pharmacy Services for Gary and Mary West PACE® in North County San Diego

Calvin H. Knowlton, PhD to address: “New Ways to Identify and Mitigate Adverse Drug Events and Get Paid for It” Calvin H. Knowlton, PhD to address: “New Ways to Identify and Mitigate Adverse Drug Events and Get Paid for It”

TRHC Chairman and CEO to Present at National Community Pharmacist Association Annual Meeting

MOORESTOWN, N.J., Oct.  10, 2019  (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, will deepen its clinical intelligence footprint through subsidiary company SinfoníaRx’s strategic partnership with Drake University’s College of Pharmacy & Health Sciences. The College, located in Des Moines, Iowa, is a nationally ranked academic program known for leadership and innovation. The partnership will provide community pharmacies additional revenue opportunities through enhanced clinical and telehealth services.

News for Tabula Rasa Healthcare Stock (TRHC)